Results 231 to 240 of about 97,061 (270)
A novel approach for inferring effects on pregnancy loss. [PDF]
Leung M +10 more
europepmc +1 more source
Effects of SGLTi on Individual Clinical Endpoints and Quality‐of‐Life: outcome from randomized data. Abstract Aims Sodium–glucose co‐transporter inhibitors (SGLTis) have cardiovascular protective effects. We aimed to assess the effects of SGLTis on individual hard clinical endpoints and quality of life (QoL) in patients with cardiovascular risk factors.
Jia Liao +27 more
wiley +1 more source
Ultra-Processed Foods and the Cardiovascular-Kidney-Metabolic Continuum: Integrating Epidemiological, Multi-Omics, and Translational Evidence. [PDF]
Singar S +12 more
europepmc +1 more source
Abstract Large clinical data underscore that heart failure is independently associated to an increased risk of negative cognitive outcome and dementia. Emerging evidence suggests that cerebral hypoperfusion, stemming from reduced cardiac output and vascular pathology, may contribute to the largely overlapping vascular dementia and Alzheimer's disease ...
Mauro Massussi +6 more
wiley +1 more source
Reply: Reassessing pre-existing comorbidity patterns in testicular cancer: controversies and future directions. [PDF]
Ornstrup MJ +3 more
europepmc +1 more source
Abstract Aims Inflammation plays a critical role in both the development and progression of heart failure (HF), which is a leading cause of morbidity and mortality worldwide. However, the causality between specific inflammation‐related proteins and HF risk remains unclear.
Xian‐Guan Zhu +9 more
wiley +1 more source
Potential protective role of vitamin C in peripheral artery disease: A Mendelian randomization and NHANES analysis. [PDF]
Dong Z, Wang Q, Hao L.
europepmc +1 more source
Long-Term PM2.5 Exposure and Clinical Skin Aging: A Systematic Review and Meta-Analysis of Pigmentary and Wrinkle Outcomes. [PDF]
Tjiu JW, Lu CF.
europepmc +1 more source
The exposure potential restriction rule revisited. [PDF]
Labrecque JA, Poole C, Stang A.
europepmc +1 more source
Metabolic syndrome and cholangiocarcinoma: large numbers, small risks, but big implications. [PDF]
Saeed U, Yaqub S.
europepmc +1 more source

